Evolutionary Tree Capital Management, LLC Charles River Laboratories International, Inc. Transaction History

Evolutionary Tree Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$183.71 - $210.25 $734 - $841	4 Added 0.07%	5,650 $1.19 Million
Q1 2023 May 09, 2023	SELL	$191.89 - $259.92 $1.9 Million - $2.57 Million	-9,889 Reduced 63.66%	5,646 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $281,670 - $357,350	-1,429 Reduced 8.42%	15,535 $3.38 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $747,639 - $1.03 Million	4,098 Added 31.85%	16,964 $3.34 Million
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $2.63 Million - $3.89 Million	12,866 New	12,866 $2.75 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Evolutionary Tree Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolutionary Tree Capital Management, LLC with notifications on news.